Hence, it is possible that FPR2-mediated hepatocyte survival leads to reduced inflammation and fibrosis, which are commonly observed in NASH accompanied by massive hepatocyte death. This evidence concerns the gene FPR2 and metabolic dysfunction-associated steatohepatitis.